Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications

Critical Reviews in Oncology/Hematology · Published 2026-08-01 · DOI 10.1016/j.critrevonc.2026.105511

Free full text

Authors (13)

Michele Massimino, Stefania Stella, Giuseppe Di Grazia, Cristina Tomarchio, Silvia Rita Vitale, Federica Martorana, Gabriella Pellegriti, Gaetano Magro, Giuseppe Broggi, Lucia Salvatorelli, Rosario Caltabiano, Livia Manzella, Paolo Vigneri

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Massimino, M., Stella, S., Grazia, G., et al. (2026). Revisiting Diffuse Gliomas in the Era of Precision Medicine: Molecular Insights and Therapeutic Implications. Critical Reviews in Oncology/Hematology. https://doi.org/10.1016/j.critrevonc.2026.105511

Related articles

• cIMPACT ‐ NOW update 11: Proposal on adaptation of diagnostic criteria for IDH ‐ and H3 ‐wildtype diffuse high‐grade gliomas and for posterior fossa ependymal tumors · Brain Pathology · 2025 · Cites or is cited by this article
• TROP-2 in solid tumors: From oncogenic driver to therapeutic target with antibody-drug conjugates · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Circulating tumour DNA and molecular residual disease in oesophageal cancer: Clinical readiness, evidence gaps and trial-ready applications · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Molecular mechanisms of targeted therapy in breast cancer: An integrated signaling network perspective · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• The adipose microenvironment in colorectal cancer: Navigating the nexus of inflammation, metabolism, and metastatic reprogramming · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Biomimetic nanoparticles for metastatic breast cancer: Advancing targeted drug delivery beyond conventional nanomedicine · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Remodeling the immune microenvironment: Engineering IL-2 variants to overcome clinical bottlenecks in PD-1 inhibitor plus chemotherapy · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Extracellular vesicle-mediated immunity-coagulation interaction in cancer-associated thrombosis during the immunotherapy era · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Liquid biopsy for early cancer detection in hereditary cancer syndromes: Current evidence · Critical Reviews in Oncology/Hematology · 2026 · Same journal
• Current status and prospects of chemotherapy-free strategies in ovarian cancer · Critical Reviews in Oncology/Hematology · 2026 · Same journal